- Report
- April 2023
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Lanthanum Carbonate is a drug used to treat hyperphosphatemia, a condition caused by elevated levels of phosphate in the blood. It is commonly used in the treatment of liver and kidney disorders, such as chronic kidney disease, end-stage renal disease, and primary hyperparathyroidism. The drug works by binding to phosphate in the gut, preventing its absorption into the bloodstream.
Lanthanum Carbonate is available in both oral and injectable forms. It is generally well-tolerated, with few side effects. Common side effects include nausea, vomiting, and constipation. It is important to note that Lanthanum Carbonate should not be used in patients with severe renal impairment.
The Lanthanum Carbonate market is highly competitive, with several major players. Some of the leading companies in the market include Sanofi, Teva Pharmaceuticals, and Mylan. Other companies include Lupin, Sun Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more